Literature DB >> 31802267

Implication of Coformer Structural Diversity on Cocrystallization Outcomes of Telmisartan with Improved Biopharmaceutical Performance.

Jamshed Haneef1,2, Poonam Arora3, Renu Chadha4.   

Abstract

Crystal engineering approach was utilized for the development of different multicomponent solid forms of telmisartan (TEL) to improve its oral bioavailability. In this context, two cocrystals, gentisic acid (GA) and maleic acid (MA), while two eutectic mixtures, para-aminobenzoic acid (PABA) and adipic acid (AA), were successfully prepared and characterized by different analytical tools. Both the cocrystals exhibited characteristic heterosynthons, viz. OHacid⋯Narom and OHacid⋯O, to propagate new network. Structural features of coformers has been correlated with the outcomes of cocrystallization approach. Coformers having auxiliary functionality in addition to complementary functional groups have high propensity to generate cocrystals. However, multicomponent where auxiliary functionality is lacking, such combinations, is shown to form eutectic mixtures owing to strong homomeric interaction. Besides, the developed cocrystals and eutectic mixtures showed higher aqueous solubility (3-5.5-fold) and intrinsic dissolution rate (1-2.6-fold) over pure TEL. In vivo studies also revealed significant improvement in relative bioavailability (2-2.6-fold). The study also shed light on the implications of eutectic mixtures in mitigating the solubility issues of drugs which are often considered negative results of cocrystallization strategy.

Entities:  

Keywords:  bioavailability; cocrystals; crystal engineering; eutectic mixtures; multicomponent solid forms

Mesh:

Substances:

Year:  2019        PMID: 31802267     DOI: 10.1208/s12249-019-1559-9

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  1 in total

1.  Effect of pH Modifiers on the Solubility, Dissolution Rate, and Stability of Telmisartan Solid Dispersions Produced by Hot-melt Extrusion Technology.

Authors:  Ahmed Almotairy; Mashan Almutairi; Abdulmajeed Althobaiti; Mohammed Alyahya; Sandeep Sarabu; Abdullah Alzahrani; Feng Zhang; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2021-06-29       Impact factor: 5.062

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.